Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- 135,000 square-foot state-of-the-art gene therapy manufacturing facility located in Sanford, N.C., officially opened June 8 - Facility to support clinical- and commercial-scale manufacturing of...
- Addressing everyday challenges in cancer care; apply by June 3, 2022 - NORTHBROOK, Ill., April 25, 2022 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") today announced that it is accepting...
- Vcreate and Weatherwax Biotechnologies win a year of access to life-science incubator in San Francisco, CA and to Astellas expertise to further their research - TOKYO and SAN FRANCISCO, Dec. 14,...
-Thymmune Therapeutics and M13 Therapeutics win a year of access to life-science incubator in Cambridge, MA and access to Astellas expertise to further their research- CAMBRIDGE, Mass., Nov. 3, 2021 /
Astellas ranked again in Seramount's 100 Best Companies and Best Companies for Dads lists. NORTHBROOK, Ill., Sept. 28, 2021 /PRNewswire/ -- Seramount (formerly Working Mother Media) revealed its...
Read more about Astellas Recognized Consistently Among Top Companies for Working Parents
Sponsorship provides a year of access to MBC BioLabs' life-science incubators and in-house Astellas expertise for scientific innovators TOKYO and SAN FRANCISCO, Sept. 21, 2021 /PRNewswire/ --...
Astellas' "Future Innovator Prize" sponsorship provides access to life-science incubator and in-house Astellas expertise for scientific entrepreneurs with cutting-edge ideas CAMBRIDGE, Mass., Aug....
- PROGRAF Becomes First Immunosuppressive Drug Approved in the U.S. for People Receiving a Lung Transplant - NORTHBROOK, Ill., July 20, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503,...
- Three innovators awarded $200,000 in total grants and resources for their work to "Change Cancer Care" beyond medicine - NORTHBROOK, Ill., March 24, 2021 /PRNewswire/ -- Astellas Pharma US, Inc....
Read more about Astellas Oncology Announces Grand Prize Winner of Fifth Annual C³ Prize® Challenge
Oncology head Mark Reisenauer named Astellas US President; Masahide Goto named President at Astellas Institute for Regenerative Medicine NORTHBROOK, Ill. and BOSTON, Feb. 4, 2021 /PRNewswire/ --...
NORTHBROOK, Ill., Jan. 28, 2021 /PRNewswire/ -- For the seventh consecutive year, Astellas has achieved a perfect score on the Human Rights Campaign Foundation's (HRC) annual Corporate Equality Index
Sponsorship provides a year of access to MBC BioLabs' life-science incubators and in-house Astellas expertise SAN FRANCISCO, Dec. 14, 2020 /PRNewswire/ -- Astellas Venture Management (President:...
- AXONIS Therapeutics, Inc. and Tenza win a year of access to life-science incubator in Cambridge, MA and access to Astellas expertise to further their research - CAMBRIDGE, Mass., Oct. 8, 2020...
- 11th Annual Changing Tomorrow Day Enables Employees to Support Frontline Workers in Hospitals, Homeless and Hospitalized Veterans and Others in Need - NORTHBROOK, Ill., Oct. 1, 2020 /PRNewswire/...
Sponsorship provides a year of access to MBC BioLabs' life-science incubators and in-house Astellas expertise for scientific innovators TOKYO and SAN FRANCISCO, Sept. 29, 2020 /PRNewswire/ --...
NORTHBROOK, Ill., Sept. 23, 2020 /PRNewswire/ -- Astellas today announced the structure and operating model for its global Patient Centricity organization designed to support the development of...
NORTHBROOK, Ill., Sept. 15, 2020 /PRNewswire/ -- Astellas again ranked among the top companies for working parents in Working Mother Magazine's 2020 "100 Best Companies" list for both working...
Read more about Astellas Ranks Among Top Companies for Working Parents
Recent grants and redirected funding help to respond to the COVID-19 pandemic by improving healthcare infrastructure, training and education in low-income countries NORTHBROOK, Ill., Sept. 1, 2020...
-Tackling everyday challenges in cancer care, apply by September 28, 2020- NORTHBROOK, Ill., Aug. 4, 2020 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") today announced the call for entries...
Astellas "Golden Ticket" sponsorship provides access to life-science incubator and in-house Astellas expertise for scientific entrepreneurs with cutting-edge ideas CAMBRIDGE, Mass., July 23, 2020...
NORTHBROOK, Ill., May 27, 2020 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food and Drug Administration...
NORTHBROOK, Ill., April 30, 2020 /PRNewswire/ -- With more and more Americans facing economic hardships as a result of the COVID-19 pandemic, Astellas has implemented changes to its patient...
- New Funding will Address Disparities in Mental Health Diagnosis and Treatment for 400,000 People in Need - NORTHBROOK, Ill. and INDIANAPOLIS, Feb. 10, 2020 /PRNewswire/ -- The Astellas Global...
NORTHBROOK, Ill., Jan. 21, 2020 /PRNewswire/ -- For the sixth consecutive year, Astellas has achieved a perfect score on the Human Rights Campaign Foundation's (HRC) annual Corporate Equality...
NORTHBROOK, Ill., Jan. 8, 2020 /PRNewswire/ -- Astellas Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for...
Follow U.S. news
